Activin and Inhibin

FABP-IN-1 (Compounds 4b) is a high affinity fatty acid binding protein (FABP) inhibitor. FABP-IN-1 inhibits FABP3 , FABP5 , and FABP7 with K i values of 0.69 μM, 0.55 μM and 0.67 μM, respectively. FABP-IN-1 displays potent antinociceptive effectsIn

FABP5-IN-1 is a selective and high affinity fatty acid binding protein 5 (FABP5) inhibitor with a K i value of 1.7 μM, and does not bind to both FABP3 and FABP7. FABP5-IN-1 shows potent antinociceptive effectsIn VivoFABP5-IN-1 (Compounds 4j: 20

FABP5-IN-1 is a selective and high affinity fatty acid binding protein 5 (FABP5) inhibitor with a K i value of 1.7 μM, and does not bind to both FABP3 and FABP7. FABP5-IN-1 shows potent antinociceptive effectsIn VivoFABP5-IN-1 (Compounds 4j: 20

FABP5-IN-1 is a selective and high affinity fatty acid binding protein 5 (FABP5) inhibitor with a K i value of 1.7 μM, and does not bind to both FABP3 and FABP7. FABP5-IN-1 shows potent antinociceptive effectsIn VivoFABP5-IN-1 (Compounds 4j: 20

FABP5-IN-1 is a selective and high affinity fatty acid binding protein 5 (FABP5) inhibitor with a K i value of 1.7 μM, and does not bind to both FABP3 and FABP7. FABP5-IN-1 shows potent antinociceptive effectsIn VivoFABP5-IN-1 (Compounds 4j: 20

FABP5-IN-1 is a selective and high affinity fatty acid binding protein 5 (FABP5) inhibitor with a K i value of 1.7 μM, and does not bind to both FABP3 and FABP7. FABP5-IN-1 shows potent antinociceptive effectsIn VivoFABP5-IN-1 (Compounds 4j: 20

FABPs ligand 6 (MF6) is an FABP5 and FABP7 inhibitor with K D values of 874 nM and 20 nM, respectively. FABPs ligand 6 can be used for multiple sclerosis research.Appearance:SolidIC50&amp: Target:K D : 20 nM (FABP7), 874 nM (FABP5)In Vitro:FABPs

FABPs ligand 6 (MF6) is an FABP5 and FABP7 inhibitor with K D values of 874 nM and 20 nM, respectively. FABPs ligand 6 can be used for multiple sclerosis research.Appearance:SolidIC50&amp: Target:K D : 20 nM (FABP7), 874 nM (FABP5)In Vitro:FABPs

FABPs ligand 6 (MF6) is an FABP5 and FABP7 inhibitor with K D values of 874 nM and 20 nM, respectively. FABPs ligand 6 can be used for multiple sclerosis research.Appearance:SolidIC50&amp: Target:K D : 20 nM (FABP7), 874 nM (FABP5)In Vitro:FABPs

Fanotaprim is a dihydrofolate reductase (DHFR) inhibitor with IC 50 s of 1.57 and 308 nM for tg DHFR ( Toxoplasma gondii DHFR) and hDHFR (human DHFR), respectively. Fanotaprim has the potential for the research of toxoplasmosis.In VitroFanotaprim

Fanotaprim is a dihydrofolate reductase (DHFR) inhibitor with IC 50 s of 1.57 and 308 nM for tg DHFR ( Toxoplasma gondii DHFR) and hDHFR (human DHFR), respectively. Fanotaprim has the potential for the research of toxoplasmosis.In VitroFanotaprim

Fanotaprim is a dihydrofolate reductase (DHFR) inhibitor with IC 50 s of 1.57 and 308 nM for tg DHFR ( Toxoplasma gondii DHFR) and hDHFR (human DHFR), respectively. Fanotaprim has the potential for the research of toxoplasmosis.In VitroFanotaprim